Sleep medications are not all equally risky, but most carry real downsides, especially with regular use. Short-term, they can cause next-day drowsiness, dizziness, and memory problems. Long-term, the picture gets more concerning: a 10-year prospective study found that regular sleep medication use was associated with a 30% increased risk of developing dementia. Whether a sleep aid is “bad for you” depends on which type you’re taking, how often, and for how long.
How Sleep Medications Work on Your Brain
Most prescription sleep drugs work by amplifying the activity of GABA, your brain’s main “slow down” chemical. Benzodiazepines and the newer “Z-drugs” (zolpidem, zopiclone, zaleplon) both target GABA receptors to sedate you, though Z-drugs are more narrowly targeted at the specific receptor subunit tied to sleepiness. The result is similar: your brain’s arousal centers quiet down, and you fall asleep faster.
A newer class works differently, blocking orexin, a chemical that keeps you awake. These tend to produce fewer of the heavy, drugged feelings associated with older medications. Melatonin-based options, both prescription and over-the-counter, work on your brain’s internal clock rather than sedating you directly, which is why they feel milder.
Over-the-counter sleep aids like diphenhydramine (the active ingredient in many PM-branded products) are antihistamines. They make you drowsy as a side effect of blocking histamine, but they also block a brain chemical called acetylcholine, and that’s where problems start to build up over time.
Common Side Effects Across All Types
The FDA warns that all insomnia medicines can impair driving and alertness the morning after use, even if you feel fully awake. That gap between feeling alert and actually being alert is one of the most underappreciated risks. Common side effects include drowsiness, dizziness, diarrhea, and a groggy, drugged feeling. Less common but more serious effects include memory loss and decreased mental sharpness.
The FDA has also added its strongest safety label, a boxed warning, to several prescription sleep drugs because of “complex sleep behaviors.” These are episodes where people get out of bed while not fully conscious and do things like walk around, drive a car, or prepare food with no memory of it afterward. These events are rare, but they have caused serious injuries and deaths.
Over-the-Counter Sleep Aids Aren’t Safer
Many people assume that because diphenhydramine is available without a prescription, it must be harmless for regular use. It isn’t. Diphenhydramine is a strong anticholinergic, meaning it blocks a brain signaling system involved in memory and learning. A prospective cohort study found that higher cumulative use of strong anticholinergics, including diphenhydramine, is associated with an increased risk of dementia.
Tolerance also develops quickly. After a few nights, the drowsiness effect weakens, which leads many people to increase their dose. The anticholinergic burden on the brain, however, continues to accumulate regardless of whether the sleep benefit fades. For this reason, these products are particularly concerning for older adults, who are already more vulnerable to cognitive decline.
Long-Term Risks: Dementia, Cancer, and Mortality
The long-term safety data on sleep medications is troubling. Out of 46 epidemiologic studies that examined whether hypnotic drugs are linked to mortality, 43 found an association with increased risk of death. That’s a striking level of consistency across different study designs and populations.
A large meta-analysis of 22 prospective studies covering nearly 2.5 million participants found that benzodiazepine use was associated with a 25% increase in cancer risk. The association showed dose-response and dose-duration relationships, meaning the more you take and the longer you take it, the stronger the link becomes.
Dementia risk is another major concern. A national U.S. study tracking participants over 10 years, published in the American Journal of Preventive Medicine, found that sleep medication use was significantly associated with a 30% higher risk of developing dementia. These are observational findings, so they don’t prove the medications directly cause these outcomes. But the pattern is consistent enough across many studies that the risk is taken seriously by sleep medicine specialists.
Dependence and Withdrawal
Your body adapts to sedative medications faster than you might expect. Once it does, stopping abruptly can trigger withdrawal symptoms including anxiety, tremors, nightmares, insomnia, rapid pulse, and in severe cases, seizures. The timeline varies by drug. For shorter-acting medications, withdrawal symptoms can begin within 12 to 24 hours of the last dose and peak at 24 to 72 hours. For longer-acting ones, symptoms may not start for one to two days and can peak anywhere from five to eight days later.
Rebound insomnia, where your sleep is temporarily worse than it was before you started the medication, is one of the most common withdrawal effects and one of the main reasons people stay on sleep drugs longer than intended. It creates a cycle: you try to stop, sleep terribly for a few nights, and conclude that you “need” the medication. In reality, the bad sleep is often the drug leaving your system, not your original insomnia returning.
What About Melatonin?
Melatonin occupies a different category. It’s a hormone your brain already produces to signal nighttime, and supplemental melatonin works by nudging your internal clock rather than sedating you. A common concern is whether taking it long-term disrupts your body’s own hormone production. Current evidence is reassuring on that front: a six-month supplementation study found no significant changes in thyroid hormones, reproductive hormones, or other endocrine markers. Although melatonin can temporarily suppress certain reproductive hormones, these effects don’t appear to persist.
That said, melatonin is most effective for circadian rhythm issues, like jet lag or a sleep schedule that’s shifted too late, rather than for the kind of insomnia where you’re lying awake despite being tired. If your problem is difficulty staying asleep or waking too early, melatonin is unlikely to help much.
CBT-I Outperforms Medication Long-Term
The American Academy of Sleep Medicine gives its strongest recommendation to cognitive behavioral therapy for insomnia (CBT-I) as the treatment of choice for chronic insomnia. This isn’t a soft endorsement. It’s the only insomnia intervention that received their highest-level recommendation.
CBT-I is a structured program, typically four to eight sessions, that retrains your sleep habits and addresses the anxious thought patterns that keep you awake. It includes techniques like sleep restriction (counterintuitively spending less time in bed to build stronger sleep drive), stimulus control (relearning to associate your bed with sleep rather than wakefulness), and cognitive restructuring for nighttime worry.
The comparative data is clear. While medications may work slightly better in the first few weeks, CBT-I pulls ahead over time. Studies show CBT-I improves sleep efficiency by 8 to 16 percent and reduces the time it takes to fall asleep by 30 to 45 minutes. More importantly, these improvements last. One study tracked patients for 24 months after treatment: those who received CBT-I showed continued improvement on a standardized sleep quality scale, while those treated with medication had actually gotten worse. Another study at eight months found that CBT-I patients’ sleep quality improved by an average of 1.2 points on a standard index, while medication patients worsened by 0.8 points.
The effects of medication tend to decline once you stop taking it, or even while you’re still on it as tolerance builds. CBT-I teaches skills that compound over time. The tradeoff is that it requires more effort upfront and may take a few weeks to show results, while a pill works the first night.
When Medication Makes Sense
None of this means sleep medications should never be used. Acute insomnia from a crisis, a medical procedure, jet lag, or a short stretch of terrible sleep can be a reasonable time for short-term medication. The risks described above are largely dose-dependent and duration-dependent. A few nights of a sleep aid during a difficult period is a very different risk profile from nightly use for months or years.
The problems accumulate with chronic use: dependence, next-day impairment, cognitive effects, and the statistical links to dementia, cancer, and mortality. If you’ve been taking a sleep medication regularly for more than a few weeks, tapering off gradually rather than stopping suddenly is important to avoid withdrawal symptoms. Combining a gradual taper with CBT-I techniques gives the best chance of sleeping well without ongoing medication.